cas 2105905-46-0|| where to buy 4,6-dichloro-1H-pyrazolo[3,4-b]pyridine

Product Name:4,6-dichloro-1H-pyrazolo[3,4-b]pyridine

IUPAC Name:4,6-dichloro-1H-pyrazolo[3,4-b]pyridine

Packing Unit	Available Stock	Price($)
CM325579-1g	in stock	ƿŤ
CM325579-5g	in stock	ŤƿǪ

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Additional Notes

Verification code*

refresh

: CAS NO:2105905-46-0; Molecular Formula:C6H3Cl2N3; Melting Point:-; Smiles Code:ClC1=CC(Cl)=C2C(NN=C2)=N1; Density:

: Catalog Number:CM325579; Molecular Weight:188.01; Boiling Point:; MDL No:; Storage:Keep in a tight container and store at 2°C~8°C for long term and which can be kept in a tight container at ambient temperature f

: Pyrazolopyridines; Over the past few years, many pyrazole fused-ring systems, especially with applications in medicinal chemistry, have been published. These include general structures such as pyrazoline, pyrazoline, pyrazoquinoline, pyrazoloisoquinoline, pyrazoline, pyrazolopyrazine, pyrazolopyrazine, pyranopyrazole, pyrano Pyrazoles, pyrazolotriazines and pyrazole fused phosphorus rings.

: Quemliclustat; Data from a phase 1b study of Quemliclustat-based regimens showed promising overall survival in treatment-naïve metastatic pancreatic cancer. Median Overall Survival was 15.7 months for all patients treated with 100 mg quemliclustat-based regimens in the ARC-8 study, which exceeds the historical benchmark data for chemotherapy alone.
Quemliclustat is an investigational, potent and selective small molecule CD73 inhibitor. CD73 is the primary enzymatic producer of immunosuppressive adenosine in the tumor microenvironment, and high CD73 expression is associated with significantly poorer prognosis in several tumor types. Quemliclustat has been shown to block the production of adenosine. Once the immunosuppressive effects of adenosine are removed, activation of antitumor immune cells may be restored, resulting in cancer cell death.